Kira gets clearance for bifunctional biologic trial in China, Australia
Kira Pharmaceuticals has received clearances in China and Australia to commence Phase II trials of KP104 for IgAN and C3G.
Source: clinicaltrialsarena.com
Inds Kira News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Inds Kira. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Inds Kira Today - Breaking & Trending Today
Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia
/PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases,...
Source: prnewswire.com
Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Au
CAMBRIDGE, Mass., Dec. 20, 2022 /PRNewswire/ — Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases,...
Source: fnarena.com